JP2022547416A5 - - Google Patents

Info

Publication number
JP2022547416A5
JP2022547416A5 JP2022513059A JP2022513059A JP2022547416A5 JP 2022547416 A5 JP2022547416 A5 JP 2022547416A5 JP 2022513059 A JP2022513059 A JP 2022513059A JP 2022513059 A JP2022513059 A JP 2022513059A JP 2022547416 A5 JP2022547416 A5 JP 2022547416A5
Authority
JP
Japan
Prior art keywords
sequence
sequence number
immune
responsive
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022513059A
Other languages
English (en)
Japanese (ja)
Other versions
JP7723420B2 (ja
JP2022547416A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/074071 external-priority patent/WO2021038036A1/en
Publication of JP2022547416A publication Critical patent/JP2022547416A/ja
Publication of JP2022547416A5 publication Critical patent/JP2022547416A5/ja
Application granted granted Critical
Publication of JP7723420B2 publication Critical patent/JP7723420B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022513059A 2019-08-28 2020-08-28 B細胞標的化並列CAR(pCAR)治療的薬剤 Active JP7723420B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962892936P 2019-08-28 2019-08-28
US62/892,936 2019-08-28
US202062983451P 2020-02-28 2020-02-28
US62/983,451 2020-02-28
PCT/EP2020/074071 WO2021038036A1 (en) 2019-08-28 2020-08-28 B CELL TARGETED PARALLEL CAR (pCAR) THERAPEUTIC AGENTS

Publications (3)

Publication Number Publication Date
JP2022547416A JP2022547416A (ja) 2022-11-14
JP2022547416A5 true JP2022547416A5 (cg-RX-API-DMAC7.html) 2023-09-04
JP7723420B2 JP7723420B2 (ja) 2025-08-14

Family

ID=72560541

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022513059A Active JP7723420B2 (ja) 2019-08-28 2020-08-28 B細胞標的化並列CAR(pCAR)治療的薬剤

Country Status (5)

Country Link
US (1) US12534507B2 (cg-RX-API-DMAC7.html)
EP (1) EP4021485A1 (cg-RX-API-DMAC7.html)
JP (1) JP7723420B2 (cg-RX-API-DMAC7.html)
CN (1) CN114641308A (cg-RX-API-DMAC7.html)
WO (1) WO2021038036A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019377461A1 (en) * 2018-11-06 2021-05-27 Washington University Chimeric antigen receptor memory-like (CARML) NK cells and methods of making and using same
GB201900858D0 (en) * 2019-01-22 2019-03-13 Price Nicola Kaye Receptors providing targeted costimulation for adoptive cell therapy
KR20210137085A (ko) 2019-03-05 2021-11-17 엔카르타, 인크. Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도
JP7723420B2 (ja) 2019-08-28 2025-08-14 キングス・カレッジ・ロンドン B細胞標的化並列CAR(pCAR)治療的薬剤
WO2021250428A1 (en) * 2020-06-11 2021-12-16 Quell Therapeutics Limited Trem2 chimeric receptor
WO2022094314A1 (en) * 2020-10-30 2022-05-05 The University Of North Carolina At Chapel Hill Dual targeting chimeric antigen receptors
CA3213040A1 (en) * 2021-03-22 2022-09-29 Michel Sadelain Cd38 chimeric co-stimulating receptor and uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000034309A1 (en) * 1998-12-04 2000-06-15 Dana-Farber Cancer Institute, Inc. Cloning and characterization of a cd2 binding protein (cd2bp2)
US7321026B2 (en) * 2001-06-27 2008-01-22 Skytech Technology Limited Framework-patched immunoglobulins
US7446190B2 (en) 2002-05-28 2008-11-04 Sloan-Kettering Institute For Cancer Research Nucleic acids encoding chimeric T cell receptors
WO2007147901A1 (en) * 2006-06-22 2007-12-27 Novo Nordisk A/S Production of bispecific antibodies
MX2011008611A (es) 2009-02-16 2011-10-21 Biolex Therapeutics Inc Anticuerpos anti-cd20 humanizados y metodos de uso.
US9845362B2 (en) * 2010-10-08 2017-12-19 The University Of North Carolina At Charlotte Compositions comprising chimeric antigen receptors, T cells comprising the same, and methods of using the same
PH12013501201A1 (en) * 2010-12-09 2013-07-29 Univ Pennsylvania Use of chimeric antigen receptor-modified t cells to treat cancer
RU2729401C2 (ru) * 2012-10-02 2020-08-06 Мемориал Слоан-Кеттеринг Кэнсер Сентер Композиции и способы для иммунотерапии
UY35468A (es) * 2013-03-16 2014-10-31 Novartis Ag Tratamiento de cáncer utilizando un receptor quimérico de antígeno anti-cd19
CA2935748A1 (en) 2014-02-25 2015-09-03 Immunomedics, Inc. Humanized rfb4 anti-cd22 antibody
ES2751915T5 (es) * 2014-08-15 2022-12-23 Merck Patent Gmbh Proteínas de fusión de inmunoglobulina con SIRP alfa
GB201503742D0 (en) 2015-03-05 2015-04-22 Ucl Business Plc Chimeric antigen receptor
GB201513540D0 (en) 2015-07-31 2015-09-16 King S College London Therapeutic agents
US20190112380A1 (en) * 2016-03-29 2019-04-18 University Of Southern California Chimeric antigen receptors targeting cancer
BR102018008260A2 (pt) 2017-04-24 2020-04-28 Kite Pharma, Inc. domínios de ligação ao antígeno humanizado e métodos de uso
CN108220247A (zh) * 2018-03-20 2018-06-29 杭州史迪姆生物科技有限公司 一种双car-t细胞及其制备方法和应用
CN109485732B (zh) 2018-12-20 2021-09-24 四川大学华西医院 基因工程修饰的双靶点嵌合抗原受体及其用途
JP7723420B2 (ja) 2019-08-28 2025-08-14 キングス・カレッジ・ロンドン B細胞標的化並列CAR(pCAR)治療的薬剤

Similar Documents

Publication Publication Date Title
JP2020525032A5 (cg-RX-API-DMAC7.html)
CN114502591B (zh) 靶向bcma的抗体、双特异性抗体及其用途
JP2022058345A5 (cg-RX-API-DMAC7.html)
CN111018986B (zh) 抗磷脂酰肌醇蛋白多糖-3的抗体及其应用
JP2018519263A5 (cg-RX-API-DMAC7.html)
JP2020511152A5 (cg-RX-API-DMAC7.html)
JP2018508215A5 (cg-RX-API-DMAC7.html)
JP2021534762A5 (cg-RX-API-DMAC7.html)
JP2021534096A5 (cg-RX-API-DMAC7.html)
JP2018528776A5 (cg-RX-API-DMAC7.html)
JP2023526774A5 (cg-RX-API-DMAC7.html)
JP2021522844A5 (cg-RX-API-DMAC7.html)
JP2022512882A5 (cg-RX-API-DMAC7.html)
JP2015163068A5 (cg-RX-API-DMAC7.html)
JP2019501883A5 (cg-RX-API-DMAC7.html)
CN106749677B (zh) 一种靶向mll白血病的双特异性嵌合抗原受体基因及其应用
JP2021503006A5 (cg-RX-API-DMAC7.html)
JP2023540526A5 (cg-RX-API-DMAC7.html)
JP2018522541A5 (cg-RX-API-DMAC7.html)
JPWO2021131021A5 (cg-RX-API-DMAC7.html)
JP2022521705A5 (cg-RX-API-DMAC7.html)
JP2012501670A5 (cg-RX-API-DMAC7.html)
JP2022553129A5 (cg-RX-API-DMAC7.html)
JP2022523710A5 (cg-RX-API-DMAC7.html)
JP2024541680A5 (cg-RX-API-DMAC7.html)